These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10028915)

  • 21. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SDS-PAGE/immunoblot detection of Abeta multimers in human cortical tissue homogenates using antigen-epitope retrieval.
    Rosen RF; Tomidokoro Y; Ghiso JA; Walker LC
    J Vis Exp; 2010 Apr; (38):. PubMed ID: 20418805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.
    Thal DR; Ghebremedhin E; Haass C; Schultz C
    Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease.
    Behrouz N; Defossez A; Delacourte A; Mazzuca M
    J Gerontol; 1991 Nov; 46(6):B209-12. PubMed ID: 1719062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical localization of amyloid beta-protein with amino-terminal aspartate in the cerebral cortex of patients with Alzheimer's disease.
    Arai T; Akiyama H; Ikeda K; Kondo H; Mori H
    Brain Res; 1999 Mar; 823(1-2):202-6. PubMed ID: 10095028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
    Cho HS; Hyman BT; Greenberg SM; Rebeck GW
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
    Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
    Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
    Hoshi A; Yamamoto T; Shimizu K; Ugawa Y; Nishizawa M; Takahashi H; Kakita A
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.
    Kowa H; Sakakura T; Matsuura Y; Wakabayashi T; Mann DM; Duff K; Tsuji S; Hashimoto T; Iwatsubo T
    Am J Pathol; 2004 Jul; 165(1):273-81. PubMed ID: 15215182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aβ38 in the brains of patients with sporadic and familial Alzheimer's disease and transgenic mouse models.
    Reinert J; Martens H; Huettenrauch M; Kolbow T; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Bayer TA; Wirths O
    J Alzheimers Dis; 2014; 39(4):871-81. PubMed ID: 24305500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.
    Beach TG; Maarouf CL; Intorcia A; Sue LI; Serrano GE; Lu M; Joshi A; Pontecorvo MJ; Roher AE
    J Alzheimers Dis; 2018; 61(4):1509-1516. PubMed ID: 29376867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ.
    Philipson O; Lord A; Lalowski M; Soliymani R; Baumann M; Thyberg J; Bogdanovic N; Olofsson T; Tjernberg LO; Ingelsson M; Lannfelt L; Kalimo H; Nilsson LN
    Neurobiol Aging; 2012 May; 33(5):1010.e1-13. PubMed ID: 22118948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral amyloid β(42) deposits and microvascular pathology in ageing baboons.
    Ndung'u M; Härtig W; Wegner F; Mwenda JM; Low RW; Akinyemi RO; Kalaria RN
    Neuropathol Appl Neurobiol; 2012 Aug; 38(5):487-99. PubMed ID: 22126319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.
    Goldstein LE; Muffat JA; Cherny RA; Moir RD; Ericsson MH; Huang X; Mavros C; Coccia JA; Faget KY; Fitch KA; Masters CL; Tanzi RE; Chylack LT; Bush AI
    Lancet; 2003 Apr; 361(9365):1258-65. PubMed ID: 12699953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.